Related Experiment Video
Updated: Feb 14, 2026

Design of an Open-Source, Low-Cost Bioink and Food Melt Extrusion 3D Printer
Published on: March 2, 2020
In Situ Salt Formation during Melt Extrusion for Improved Chemical Stability and Dissolution Performance of a
Abbe Haser1, Tu Cao1, Joseph W Lubach2
1Division of Pharmaceutics, College of Pharmacy , The University of Texas at Austin , 2409 University Avenue , A1920, Austin , Texas 78712 , United States.
Adding meglumine to meloxicam amorphous solid dispersions (ASDs) prevents drug degradation during melt extrusion. This novel approach enhances drug stability and improves dissolution performance, offering a promising solution for poorly soluble compounds.
Area of Science:
- Pharmaceutical Sciences
- Materials Science
- Drug Delivery
Background:
- Poorly soluble compounds pose challenges in drug development, particularly concerning degradation during melt extrusion.
- Melt extrusion is a key process for creating amorphous solid dispersions (ASDs), but thermal lability of drug substances is a significant hurdle.
- Previous work indicated meglumine incorporation stabilizes meloxicam during extrusion, surpassing process optimization alone.
Purpose of the Study:
- To elucidate the mechanism of chemical stabilization of meloxicam by meglumine during melt extrusion.
- To evaluate the impact of meglumine on the physical stability and dissolution performance of meloxicam-Kollidon VA64 ASDs.
- To assess the long-term stability of meglumine-containing ASDs under accelerated storage conditions.
Main Methods:
- Melt extrusion of meloxicam-Kollidon VA64 blends with and without meglumine at a 1:1 molar ratio.
- High-Performance Liquid Chromatography (HPLC) for assessing meloxicam purity post-extrusion.
- Solid-state Nuclear Magnetic Resonance (NMR) spectroscopy to investigate drug-excipient interactions.
- Non-sink dissolution testing to evaluate drug release and supersaturation.
- Accelerated stability studies at 40 °C/75% Relative Humidity (RH) for six months.
Main Results:
- Meglumine at a 1:1 molar ratio with meloxicam ensured 100% purity of meloxicam after melt extrusion.
- Solid-state NMR confirmed proton transfer, indicating in situ salt formation between meloxicam and meglumine.
- The meglumine-containing ASD maintained meloxicam supersaturation (approximately 50-fold) for over 7.25 hours during dissolution.
- The ASD without meglumine precipitated within 2.25 hours post-pH shift.
- No significant chemical degradation, recrystallization, or moisture uptake was observed in meglumine-containing ASDs after six months of accelerated storage.
Conclusions:
- In situ salt formation between meloxicam and meglumine is the mechanism for chemical stabilization during melt extrusion.
- Meglumine incorporation significantly enhances the physical stability and dissolution performance of meloxicam ASDs.
- This strategy provides a robust method for stabilizing thermally labile drugs, improving their therapeutic potential.
Related Concept Videos
Factors Affecting Dissolution: Polymorphism, Amorphism and Pseudopolymorphism
Some polymorphic crystals possess lower aqueous solubility than their amorphous counterparts, leading to incomplete absorption. For instance, the oral suspension of Chloramphenicol, which...
Factors Affecting Dissolution: Drug Permeability, Stability and Stereochemistry
Structures of Solids
Molecular and Ionic Solids
Molecular Solids
Molecular crystalline solids, such as ice, sucrose (table sugar), and iodine, are solids that are composed of neutral molecules as their constituent units. These molecules are held together by weak intermolecular forces such as London dispersion forces, dipole-dipole interactions, or hydrogen bonds, which...
Network Covalent Solids
To break or to melt a covalent network solid, covalent bonds must be broken. Because covalent bonds are relatively strong, covalent network solids are typically...
Phase Transitions: Melting and Freezing

